Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
10612studies shown
Showing 5,005-5,016 of 10,612
Drug study icon
CompletedNCT04641143

Troriluzole for OCD

This study is completed in the United States. It is testing troriluzole for OCD.

In United States
OCDDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Biohaven Pharmaceuticals, Inc.
Condition
OCD
Drug study icon
CompletedNCT06419608

BHV-7000 Monotherapy for depression

This study is completed in the United States. It is testing BHV-7000 Monotherapy for depression.

In United States
DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Biohaven Therapeutics Ltd.
Condition
Depression
Drug study icon
TerminatedNCT01275248

Low-Dose Ondansetron for OCD

This study was terminated in the United States and in Mexico. It is testing Low-Dose Ondansetron for OCD.

In United States
OCDDrugOver 18 Years
Countries
United States, Mexico
Sponsor
Transcept Pharmaceuticals
Condition
OCD
Drug study icon
CompletedNCT01259492

Methylphenidate Hydrochloride Extended Release for ADHD

This study is completed in the United States, in Belgium, in Colombia, .... It is testing methylphenidate Hydrochloride Extended Release for ADHD.

In United States
ADHDDrugFrom 18 Years to 60 Years
Countries
United States, Belgium, Colombia, ...
Sponsor
Novartis Pharmaceuticals
Condition
ADHD
Behavioral study icon
TerminatedNCT01842542

NeuroStar TMS Therapy for depression

This study was terminated in the United States. It is testing NeuroStar TMS Therapy for depression.

In United States
DepressionBehavioralFrom 18 Years to 50 Years
Countries
United States
Sponsor
Neuronetics
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.